Publicaciones en colaboración con investigadores/as de Hospital Sagrado Corazón (27)

2024

  1. Optimizing periprosthetic fracture management and in-hospital outcome: insights from the PIPPAS multicentric study of 1387 cases in Spain

    Journal of Orthopaedics and Traumatology, Vol. 25, Núm. 1

  2. Predictors of outcomes after internal fixation of periprosthetic femoral hip fractures Subgroup analysis of the peri-implant and peri-prosthetic fractures Spanish registry (PIPPAS)

    Injury, Vol. 55, Núm. 10

2022

  1. Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study (J. Clin. Med., (2021), 10, (2885), 10.3390/jcm10132885)

    Journal of Clinical Medicine

2021

  1. BRCA1 Expression and Outcome in Patients With EGFR-Mutant NSCLC Treated With Gefitinib Alone or in Combination With Olaparib

    JTO Clinical and Research Reports, Vol. 2, Núm. 3

  2. Incidence, clinical characteristics and management of inflammatory bowel disease in spain: Large-scale epidemiological study

    Journal of Clinical Medicine, Vol. 10, Núm. 13

  3. Incidence, diagnosis, and outcome of immune-mediated thrombotic thrombocytopenic purpura: A nationwide survey by the Spanish registry of thrombotic thrombocytopenic purpura

    Journal of Clinical Apheresis, Vol. 36, Núm. 4, pp. 563-573

  4. Neurotoxicity associated with acyclovir and valacyclovir: A systematic review of cases

    Journal of Clinical Pharmacy and Therapeutics, Vol. 46, Núm. 4, pp. 918-926

  5. Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study

    American Journal of Gastroenterology, Vol. 116, Núm. 11, pp. 2250-2257

  6. The SEEN comprehensive clinical survey of adult obesity: Executive summary

    Endocrinologia, Diabetes y Nutricion, Vol. 68, Núm. 2, pp. 130-136

2019

  1. Association of PALB2 Messenger RNA Expression with Platinum-Docetaxel Efficacy in Advanced Non–Small Cell Lung Cancer

    Journal of Thoracic Oncology, Vol. 14, Núm. 2, pp. 304-310

  2. BRAF mutations classes I, II, and III in NSCLC patients included in the SLLIP trial: The need for a new pre-clinical treatment rationale

    Cancers, Vol. 11, Núm. 9

  3. EGFR first- and second-generation TKIs-there is still place for them in EGFR-mutant NSCLC patients

    Translational Cancer Research, Vol. 8, pp. S23-S47

  4. Integrin-linked kinase (ILK) and src homology 2 domain-containing phosphatase 2 (SHP2): Novel targets in EGFR-mutation positive non-small cell lung cancer (NSCLC)

    EBioMedicine, Vol. 39, pp. 207-214

  5. PIM-1 inhibition with AZD1208 to prevent osimertinib-induced resistance in EGFR-mutation positive non-small cell lung cancer

    Journal of Cancer Metastasis and Treatment, Vol. 5

2018

  1. Challenges and unanswered questions for the next decade of immune-oncology research in NSCLC

    Translational Lung Cancer Research, Vol. 7, Núm. 6, pp. 691-702

  2. Strategies for first-line immunotherapy in squamous cell lung cancer: Are combinations a game changer?

    Translational Lung Cancer Research, Vol. 7, pp. S198-S201

2017

  1. Assessment of plasma chitotriosidase activity, CCL18/PARC concentration and NP-C suspicion index in the diagnosis of Niemann-Pick disease type C: A prospective observational study

    Journal of Translational Medicine, Vol. 15, Núm. 1

  2. GRECOS Project (Genotyping Recurrence Risk of Stroke): The Use of Genetics to Predict the Vascular Recurrence after Stroke

    Stroke, Vol. 48, Núm. 5, pp. 1147-1153

2016

  1. Benchmarking en cirugía torácica. Tercera edición

    Archivos de Bronconeumologia, Vol. 52, Núm. 4, pp. 204-210

  2. Causal Model of Survival after Pulmonary Metastasectomy of Colorectal Cancer: A Nationwide Prospective Registry

    Annals of Thoracic Surgery, Vol. 101, Núm. 5, pp. 1883-1890